5-formylthiophene-3-boronic acid
Product Information
Molecular Formula
C5H5BO3S
Molecular Weight
155.97
Description
5-formylthiophene-3-boronic acid is an indispensable intermediate in the synthesis of various drugs and organic compounds. This multifarious compound finds substantial utility in modern biomedicine for the advancement of anti-cancer agents, anti-inflammatory therapeutics, and anti-diabetic remedies. Furthermore, it serves as an imperative constituent in the construction of targeted drug conveyance systems devised to combat formidable afflictions such as cancer and autoimmune disorders.
Synonyms
2-formylthiophene-4-boronic acid; (5-formylthiophen-3-yl)boronic Acid; 5-Formylthiophen-3-ylboronic acid; 5-Formylthiophene-3-boronic acid; (5-formyl-3-thienyl)boronic acid; 2-FORMYL-4-THIOPHENEBORONIC ACID; 2-Formylthiophene-4-boronicacid; 5-FORMYLTHIOPHEN-3-BORONIC ACID; 5-Formyl-3-thienylboronic acid; 5-formyl-3-thiopheneboronic acid; 4-Boronothiophene-2-carboxaldehyde; 2-formyl-4-thiopheneboronicacid; 5-Formylthiophen-3-ylboronicacid; 2-formyl thiophene-4-boronic acid; 5-Formyl-thiophene-3-boronic acid; (5-formylthiophen-3-yl)boronic Acid pound>>5-Formylthiophene-3-boronic acid
IUPAC Name
(5-formylthiophen-3-yl)boronic acid
SMILES
B(C1=CSC(=C1)C=O)(O)O
InChI
InChI=1S/C5H5BO3S/c7-2-5-1-4(3-10-5)6(8)9/h1-3,8-9H
InChI Key
ZCUFJAORCNFWOF-UHFFFAOYSA-N
Flash Point
Not applicable
Safety Information
Hazards
H302 - H317
Precautionary Statement
P280
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
156.0052454 g/mol
Monoisotopic Mass
156.0052454 g/mol
Topological Polar Surface Area
85.8Ų
Heavy Atom Count
10
Formal Charge
0
Complexity
130
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2019038362-A1 | ANTIBACTERIAL PYRROLOIMIDAZOLONES | 2017-08-24 |
| US-10517823-B1 | ROS—responsive liposomes for specific targeting | 2016-08-10 |
| US-10583083-B1 | ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages | 2016-08-10 |
| US-11179335-B1 | ROS-responsive liposomes for specific targeting | 2016-08-10 |
| JP-2017222626-A | Heterocyclic compounds | 2016-06-17 |
| AU-2015284135-A1 | Heteroaryl compounds useful as inhibitors of SUMO activating enzyme | 2014-07-01 |
| AU-2015284135-B2 | Heteroaryl compounds useful as inhibitors of SUMO activating enzyme | 2014-07-01 |
| EP-3164130-A1 | Heteroaryl compounds useful as inhibitors of sumo activating enzyme | 2014-07-01 |
| EP-3517112-A1 | Heteroaryl compounds useful as inhibitors of sumo activating enzyme | 2014-07-01 |
| JP-2017524734-A | Heteroaryl compounds useful as inhibitors of SUMO activating enzymes | 2014-07-01 |
